Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patients' Preferences in the Treatment of Hormone-sensitive Metastatic Prostate Cancer: a Discrete Choice Experiment

NCT04590976 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT04590976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04590976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patients' Preferences in the Treatment of Hormone-sensitive Metastatic Prostate Cancer: a Discrete Choice Experiment
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Completed
Start date
December 3, 2020
Completion date
February 1, 2023
Enrollment
320 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

health care utilization, patient satisfaction, prostate cancer metastatic, quality of life, radiotherapy side effect, surgery, urologic cancer